Johnson & Johnson (NYSE:JNJ)
| 148.33 Delayed Data As of 4:47pm ET |  +0.41 / +0.28%Today’s Change | 109.16 Today|||52-Week Range 157.00 | +1.69% Year-to-Date |
Latest JNJ News | Press Releases
Today’s Trading
| Previous close | 147.92 |
| Today’s open | 149.60 |
| Day’s range | 147.85 - 150.21 |
| Volume | 8,512,838 |
| Average volume (3 months) | 10,063,538 |
| Market cap | $375.1B |
Data as of 4:47pm ET, 07/15/2020
Growth & Valuation
| Earnings growth (last year) | +0.28% |
| Earnings growth (this year) | -10.96% |
| Earnings growth (next 5 years) | +6.10% |
| Revenue growth (last year) | +0.71% |
| P/E ratio | 23.1 |
| Price/Sales | 4.76 |
| Price/Book | 6.30 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| NVSNovartis | +0.42 | +0.48% |
| MRKMerck | +1.16 | +1.48% |
| PFEPfizer | +0.48 | +1.36% |
| ABBVAbbVie | +1.60 | +1.62% |
Data as of 4:47pm ET, 07/15/2020
Financials
| Next reporting date | July 16, 2020 |
| EPS forecast (this quarter) | $1.49 |
| Annual revenue (last year) | $82.1B |
| Annual profit (last year) | $15.1B |
| Net profit margin | 18.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New Brunswick, New Jersey |
Forecasts
